HIV-Induced CD4 T-Cell Depletion: An Innate Host Defense Gone Awry?

HIV 诱导的 CD4 T 细胞耗竭:先天宿主防御出了问题?

基本信息

  • 批准号:
    8411054
  • 负责人:
  • 金额:
    $ 32.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Progressive depletion of CD4 T cells is a halmark of untreated acquired immune deficiency syndrome (AIDS), yet the mechanism by which CD4 T cells die during HIV infection remains poorly understood. HIV can directly infect and kill CD4 T cels however too few productively infected cells are present in vivo to explain the masive CD4 T-cell losses that occur. Using primary human lymphoid aggregate cultures (HLAC) formed with tonsil or spleen tissue, we have explored how CD4 T cells die during HIV infection in lymphoid tissues. Our studies have revealed several surprises including: (1) Quiescent "bystander" CD4 T cells, which are not permissive to productive infection by X4-tropic HIV-1, die in huge numbers as a result of abortive viral infection accompanied by the the accumulation of incomplete viral DNA transcripts in the cytoplasm; (2) Death is not cause by a toxic effect of these DNA or other viral products; rather the CD4 T cells die as a result of a powerful innate immune response launched against the viral DNA, resulting in the production of interferon-¿ and activation of caspase-3 and caspase-1; (3) Ultimately, this response leads to inflammasome assembly and caspase-1 activation triggering the release of bioactive IL-1¿ and induction of pyroptosis, an intensely inflammatory form of programmed cell death. These events can establish a vicious cycle, whereby dying CD4 T cells release inflammatory mediators that attract additional cells for new rounds of abortive infection and death; 4) Surprisingly, HIV-mediated CD4 T cell depletion by pyroptosis can be completely blocked by specific class of FDA-approved oral sulfonylurea drugs currently used to treat type II diabetes. We now propose a set of pivotal new studies. In Specific Aim 1, we will test whether this mechanism of CD4 T cell depletion also extends to CCR5-expressing CD4 T cells that often display a higher state of cellular activation and thus might be less susceptible to abortive infection. In Specific Aim 2, we propose to identify the cytoplasmic sensor(s) that detects the viral DNA. Multiple sensors may activate the interferon response and the activation of caspase-1 within inflammasomes. In Specific Aim 3, we propose to identify the inflammasome that recruits caspase-1 to process and release IL-1¿ and to induce pyroptosis. Together, these studies will yield new insights into the mechanism(s) underlying HIV- induced depletion of CD4 T cells-the fundamental problem in AIDS. This new understanding could lead to an entirely new therapeutic approach to AIDS involving interdiction of the host innate immune response that promotes both CD4 T cell death and inflammation. This approach could form a strong adjunct to traditional antiviral therapy and might be particularly beneficial for patients exhibiting broad drug resistance or rapid progression of disease. PUBLIC HEALTH RELEVANCE: These studies seek to understand a fundamental problem in HIV/AIDS, namely how the virus causes the progressive depletion of CD4 T cells. Success in these studies will not only provide new insights into the molecular underpinnings of HIV immunopathogenesis, but also could provide exciting new approaches for preserving CD4 T cells and inhibiting inflammation thereby blocking HIV-induced disease progression. These approaches could be particularly valuable for patients who have failed multiple antiviral drug regimens or who display rapidly progressive disease.
描述(由申请人提供):CD 4 T细胞的进行性耗竭是未经治疗的获得性免疫缺陷综合征(AIDS)的一个标志,但对HIV感染期间CD 4 T细胞死亡的机制仍知之甚少。HIV可以直接感染和杀死CD 4 T细胞,但是体内很少有有效感染的细胞,无法解释发生的大量CD 4 T细胞损失。利用扁桃体或脾组织形成的原代人淋巴聚集体培养物(HLAC),我们探索了淋巴组织中HIV感染期间CD 4 T细胞是如何死亡的。我们的研究已经揭示了几个令人惊讶的结果,包括:(1)静止的“旁观者”CD 4 T细胞,其不允许嗜X4的HIV-1的生产性感染,由于伴随着不完整的病毒DNA转录物在细胞质中的积累的失败的病毒感染而大量死亡;(2)死亡不是由这些DNA或其他病毒产物的毒性作用引起的;相反,CD 4 T细胞由于针对病毒DNA发起的强大的先天免疫应答而死亡,导致干扰素的产生以及半胱天冬酶-3和半胱天冬酶-1的激活;(3)最终,这种应答导致炎性小体组装和半胱天冬酶-1激活,触发生物活性IL-1的释放。以及诱导焦亡,一种强烈的炎症形式的程序性细胞死亡。这些事件可以建立恶性循环,由此垂死的CD 4 T细胞释放炎性介质,吸引额外的细胞进行新一轮的流产感染和死亡; 4)令人惊讶的是,HIV介导的CD 4 T细胞耗竭通过焦亡可以被目前用于治疗II型糖尿病的特定类别的FDA批准的口服磺酰脲类药物完全阻断。我们现在提出一系列关键的新研究。在特定目标1中,我们将测试这种CD 4 T细胞耗竭机制是否也延伸到CCR 5表达的CD 4 T细胞,这些细胞通常表现出更高的细胞活化状态,因此可能对流产感染不太敏感。在具体目标2中,我们提出鉴定检测病毒DNA的细胞质传感器。多个传感器可以激活干扰素反应和炎症小体内的半胱天冬酶-1的激活。在具体目标3中,我们提出鉴定招募caspase-1以加工和释放IL-1并诱导细胞凋亡的炎性小体。总之,这些研究将对HIV诱导的CD 4 T细胞耗竭的潜在机制产生新的见解,这是AIDS的基本问题。这一新的认识可能会带来一种全新的艾滋病治疗方法,涉及阻断促进CD 4 T细胞死亡和炎症的宿主先天免疫反应。这种方法可以成为传统抗病毒治疗的有力辅助手段,对于表现出广泛耐药性或疾病快速进展的患者可能特别有益。 公共卫生相关性:这些研究试图了解艾滋病毒/艾滋病的一个基本问题,即病毒如何导致CD 4 T细胞的逐渐耗尽。这些研究的成功不仅将为HIV免疫发病机制的分子基础提供新的见解,而且还可以为保护CD 4 T细胞和抑制炎症从而阻断HIV诱导的疾病进展提供令人兴奋的新方法。这些方法对于多种抗病毒药物治疗失败或疾病进展迅速的患者特别有价值。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Warner C. Greene其他文献

Cytochalasin binding in lymphocytes and polymorphonuclear leukocytes.
淋巴细胞和多形核白细胞中的细胞松弛素结合。
  • DOI:
  • 发表时间:
    1976
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    C. Parker;Warner C. Greene;Hanna H. MacDonald
  • 通讯作者:
    Hanna H. MacDonald
Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
白细胞介素2诱导的酪氨酸磷酸化。
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Gordon B. Mills;Christopher May;Martha McGill;Marion Fung;Michael Baker;Robert Sutherland;Warner C. Greene
  • 通讯作者:
    Warner C. Greene
A role for cytochalasin-sensitive proteins in the regulation of calcium transport in activated human lymphocytes
  • DOI:
    10.1016/s0006-291x(75)80169-0
  • 发表时间:
    1975-07-22
  • 期刊:
  • 影响因子:
  • 作者:
    Warner C. Greene;Charles W. Parker
  • 通讯作者:
    Charles W. Parker
Analysis of Interleukin-2-dependent Signal Transduction through the Shc/Grb2 Adapter Pathway: INTERLEUKIN-2-DEPENDENT MITOGENESIS DOES NOT REQUIRE Shc PHOSPHORYLATION OR RECEPTOR ASSOCIATION
  • DOI:
    10.1074/jbc.270.48.28858
  • 发表时间:
    1995-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gerald A. Evans;Mark A. Goldsmith;James A. Johnston;Weiduan Xu;Sarah R. Weiler;Rebecca Erwin;O. M. Zack Howard;Robert T. Abraham;J. O'Shea John;Warner C. Greene;William L. Farrar
  • 通讯作者:
    William L. Farrar
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
细胞 APOBEC3G 限制静息 CD4+T 细胞中的 HIV-1 感染
  • DOI:
    10.1038/nature03493
  • 发表时间:
    2005-04-13
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Ya-Lin Chiu;Vanessa B. Soros;Jason F. Kreisberg;Kim Stopak;Wes Yonemoto;Warner C. Greene
  • 通讯作者:
    Warner C. Greene

Warner C. Greene的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Warner C. Greene', 18)}}的其他基金

Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
在脑类器官的单细胞水平上探索 HIV 相关神经认知障碍 (HAND) 和 HIV 潜伏期
  • 批准号:
    10237149
  • 财政年份:
    2019
  • 资助金额:
    $ 32.85万
  • 项目类别:
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
在脑类器官的单细胞水平上探索 HIV 相关神经认知障碍 (HAND) 和 HIV 潜伏期
  • 批准号:
    10006808
  • 财政年份:
    2019
  • 资助金额:
    $ 32.85万
  • 项目类别:
Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse
评估使用滥用药物的艾滋病毒感染者慢性炎症的根本原因
  • 批准号:
    9761514
  • 财政年份:
    2017
  • 资助金额:
    $ 32.85万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10223992
  • 财政年份:
    2017
  • 资助金额:
    $ 32.85万
  • 项目类别:
Project 2: Delineating virus and host cell-derived biomarkers predicting time to HIV rebound after treatment interruption
项目 2:描绘病毒和宿主细胞衍生的生物标志物,预测治疗中断后 HIV 反弹的时间
  • 批准号:
    10223996
  • 财政年份:
    2017
  • 资助金额:
    $ 32.85万
  • 项目类别:
Exploiting the Host-HIV Interface To Identify Biomarkers Predicting Time to Viral Rebound after Treatment Interruption
利用宿主-HIV 界面识别生物标志物,预测治疗中断后病毒反弹的时间
  • 批准号:
    9754763
  • 财政年份:
    2017
  • 资助金额:
    $ 32.85万
  • 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
  • 批准号:
    9503875
  • 财政年份:
    2013
  • 资助金额:
    $ 32.85万
  • 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
  • 批准号:
    8606334
  • 财政年份:
    2013
  • 资助金额:
    $ 32.85万
  • 项目类别:
HIV without AIDS: A Radically Different Approach to Help the Developing World
没有艾滋病的艾滋病毒:帮助发展中国家的完全不同的方法
  • 批准号:
    8856536
  • 财政年份:
    2013
  • 资助金额:
    $ 32.85万
  • 项目类别:
HIV-Induced CD4 T-Cell Depletion: An Innate Host Defense Gone Awry?
HIV 诱导的 CD4 T 细胞耗竭:先天宿主防御出了问题?
  • 批准号:
    8500196
  • 财政年份:
    2012
  • 资助金额:
    $ 32.85万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 32.85万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 32.85万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 32.85万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 32.85万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 32.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了